Details
Stereochemistry | ACHIRAL |
Molecular Formula | C17H18F3N3O3 |
Molecular Weight | 369.3383 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CC1(C)N(CCCCO)C(=O)N(C1=O)C2=CC(=C(C=C2)C#N)C(F)(F)F
InChI
InChIKey=ARBYGDBJECGMGA-UHFFFAOYSA-N
InChI=1S/C17H18F3N3O3/c1-16(2)14(25)23(15(26)22(16)7-3-4-8-24)12-6-5-11(10-21)13(9-12)17(18,19)20/h5-6,9,24H,3-4,7-8H2,1-2H3
Molecular Formula | C17H18F3N3O3 |
Molecular Weight | 369.3383 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/8136306Curator's Comment: Description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/9415227 | https://www.ncbi.nlm.nih.gov/pubmed/9798729 | https://www.ncbi.nlm.nih.gov/pubmed/7625751 | https://www.ncbi.nlm.nih.gov/pubmed/9449168 | http://adisinsight.springer.com/drugs/800005990
Sources: https://www.ncbi.nlm.nih.gov/pubmed/8136306
Curator's Comment: Description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/9415227 | https://www.ncbi.nlm.nih.gov/pubmed/9798729 | https://www.ncbi.nlm.nih.gov/pubmed/7625751 | https://www.ncbi.nlm.nih.gov/pubmed/9449168 | http://adisinsight.springer.com/drugs/800005990
RU58841 is a topically active non-steroidal antiandrogen. It demonstrated efficacy in animal models of androgen-dependent skin disorders such as acne and androgenetic alopecia. Under name of PSK 3841 was being developed by ProStrakan. It underwent clinical evaluation for the treatment of androgen-dependent conditions, such as acne and alopecia. Following the conclusion of phase II trials, no further development was reported. Based on this and the fact the compound is not listed on the companies pipeline, development is presumed discontinued.
Originator
Sources: https://www.ncbi.nlm.nih.gov/pubmed/8136306
Curator's Comment: 1994
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
RU 58841, a new specific topical antiandrogen: a candidate of choice for the treatment of acne, androgenetic alopecia and hirsutism. | 1994 Jan |
|
Preliminary pharmacokinetics and metabolism of novel non-steroidal antiandrogens in the rat: relation of their systemic activity to the formation of a common metabolite. | 1994 Oct |
|
Local inhibition of sebaceous gland growth by topically applied RU 58841. | 1995 Jun 12 |
|
Effects of topical antiandrogen and 5-alpha-reductase inhibitors on sebaceous glands in male fuzzy rats. | 1997 |
|
Importance of sebaceous glands in cutaneous penetration of an antiandrogen: target effect of liposomes. | 1997 May |
|
A controlled study of the effects of RU58841, a non-steroidal antiandrogen, on human hair production by balding scalp grafts maintained on testosterone-conditioned nude mice. | 1997 Nov |
|
Evaluation of RU58841 as an anti-androgen in prostate PC3 cells and a topical anti-alopecia agent in the bald scalp of stumptailed macaques. | 1998 Aug |
|
RU 58841-myristate--prodrug development for topical treatment of acne and androgenetic alopecia. | 2005 Jan |
Patents
Sample Use Guides
Mice: topically (5 days/week) with RU58841 1% in ethanol.
Stumptailed macaques: the topical application of RU58841 (a 5% solution in a propyleneglycol and isopropanol mixture).
Route of Administration:
Transdermal
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/9798729
RU58841 do not enhance androgen receptor transcriptional activity at 10 pM - 0.1 uM in PC3 cells.
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:32:24 UTC 2023
by
admin
on
Fri Dec 15 15:32:24 UTC 2023
|
Record UNII |
0D8FJQ0ADW
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Code | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
132981
Created by
admin on Fri Dec 15 15:32:24 UTC 2023 , Edited by admin on Fri Dec 15 15:32:24 UTC 2023
|
PRIMARY | |||
|
DTXSID20165781
Created by
admin on Fri Dec 15 15:32:24 UTC 2023 , Edited by admin on Fri Dec 15 15:32:24 UTC 2023
|
PRIMARY | |||
|
154992-24-2
Created by
admin on Fri Dec 15 15:32:24 UTC 2023 , Edited by admin on Fri Dec 15 15:32:24 UTC 2023
|
PRIMARY | |||
|
RU-58841
Created by
admin on Fri Dec 15 15:32:24 UTC 2023 , Edited by admin on Fri Dec 15 15:32:24 UTC 2023
|
PRIMARY | |||
|
0D8FJQ0ADW
Created by
admin on Fri Dec 15 15:32:24 UTC 2023 , Edited by admin on Fri Dec 15 15:32:24 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
METABOLITE ACTIVE -> PRODRUG |
IN-VIVO
|